4 ms·

Israeli scientist says Covid-19 could be treated for under $1/day

• gus_massa 5y ago
  From the research article: Page 2: > On day 6, 34 out of 47 (72%) patients in the ivermectin arm reached the endpoint, compared to 21/ 42 (50%) in the placebo arm (OR 2·62; 95% CI: 1·09-6·31). Page 21: > 57 were assigned to Ivermectin group, 7 had SARS-CoV-2 RT-PCR with Ct value >35 in the two first tests, 3 were lost for follow up, 47 were eligible for analysis > 59 were assigned to Placebo group, 14 had SARS-CoV-2 RT-PCR with Ct value >35 in the two first tests, 3 were lost for follow up, 42 were eligible for analysis Note that "Ct >35" means that the viral charge was so low that after amplifying the virus 35 times they weren't able to detect it. If we add them to the people with a good outcome, we get: 41 out of 54 (76%) patients in the ivermectin arm reached the "endpoint", compared to 35 out of 56 (61%) in the placebo arm. And this is probably not statistically significant any more.
  • NonContro 5y ago
    "Nearly 72% of volunteers treated with ivermectin tested negative for the virus by day six. In contrast, only 50% of those who received the placebo tested negative. IN ADDITION, the study looked at culture viability, meaning how infectious the patients were, and found that only 13% of ivermectin patients were infectious after six days, compared with 50% of the placebo group – almost four times as many." It calls for a bigger study.